We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

113 hedge funds and large institutions have $963M invested in Genomic Health, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

22% more call options, than puts

Call options by funds: $429K | Put options by funds: $351K

14% more capital invested

Capital invested by funds: $847M → $963M (+$116M)

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

6% more funds holding

Funds holding: 107 → 113 (+6)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
113
Holders Change
+6
Holders Change %
+5.61%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
41
Reduced
37
Closed
6
Calls
$429K
Puts
$351K
Net Calls
+$78K
Net Calls Change
+$1.12M

Top Buyers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
+$8.26M
2
BG
BlackRock Group
United Kingdom
+$4.97M
3
CCM
Camber Capital Management
Massachusetts
+$4.88M
4
Millennium Management
Millennium Management
New York
+$4.39M
5
JP Morgan Chase
JP Morgan Chase
New York
+$3.91M

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$21.2M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.8M
3
MRM
Michael R. Murphy
-$8.25M
4
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
-$1.17M
5
CIP
Champlain Investment Partners
Vermont
-$573K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$3.34M +$230K +7,065 +7%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.89M -$89.1K -2,739 -3%
PAMU
28
Pictet Asset Management (UK)
United Kingdom
$2.55M -$94.4K -2,900 -4%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$2.5M – – –
PP
30
PDT Partners
New York
$2.48M +$153K +4,700 +6%
BIM
31
BlackRock Investment Management
Delaware
$2.38M +$501K +15,389 +26%
SI
32
Scout Investments
Missouri
$2.37M +$11.4K +350 +0.5%
MFWM
33
Motley Fool Wealth Management
Virginia
$2.33M +$2.37M +72,732 New
MFAM
34
Motley Fool Asset Management
Virginia
$2.3M +$1.16M +35,756 +99%
CCMH
35
Cornerstone Capital Management Holdings
New York
$2.27M +$1.84M +56,400 +389%
GCP
36
GSA Capital Partners
United Kingdom
$2.05M +$699K +21,485 +50%
TCIM
37
TIAA CREF Investment Management
New York
$1.86M -$131K -4,038 -6%
BlackRock
38
BlackRock
New York
$1.82M +$1.84M +56,600 +15,215%
OC
39
Oppenheimer & Co
New York
$1.82M -$228K -7,000 -11%
Two Sigma Investments
40
Two Sigma Investments
New York
$1.72M +$1.49M +45,664 +571%
SIM
41
Spark Investment Management
New York
$1.63M +$866K +26,600 +109%
Wells Fargo
42
Wells Fargo
California
$1.63M -$21.3K -655 -1%
Charles Schwab
43
Charles Schwab
California
$1.58M -$179K -5,512 -10%
Citadel Advisors
44
Citadel Advisors
Florida
$1.47M +$268K +8,226 +22%
Jacobs Levy Equity Management
45
Jacobs Levy Equity Management
New Jersey
$1.37M -$29.6K -910 -2%
AllianceBernstein
46
AllianceBernstein
Tennessee
$1.13M – – –
CCM
47
Catapult Capital Management
New York
$1.12M -$541K -16,627 -32%
OAM
48
Oxford Asset Management
United Kingdom
$1.06M +$1.06M +32,692 New
RA
49
Royce & Associates
New York
$1.05M – – –
KB
50
Kimelman & Baird
New York
$1.02M -$127K -3,900 -11%
1
2
3 4 5

GHDX Hedge Fund Activity: Q4 2014 in Review

113 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2014, worth a combined $963M — up 14% from $847M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GHDX positions and 6 closed out — a net gain of 6 holders — while 41 added to existing stakes and 37 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $8.26M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $21.2M.

  • 113 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2014, up from 107 in Q3 2014.
  • Funds reported $963M of Genomic Health, Inc. stock for Q4 2014, up 14% quarter-over-quarter.
  • 12 funds opened new Genomic Health, Inc. positions in Q4 2014 and 6 closed out, a net change of +6 holders.
  • The largest Genomic Health, Inc. buyer in Q4 2014 was BlackRock Advisors, an estimated $8.26M added.
  • The largest Genomic Health, Inc. seller in Q4 2014 was TPG Group Holdings (SBS) Advisors, an estimated $21.2M sold.

Based on aggregated 13F filings for Q4 2014.